IDiyas

For the Inventor, By the Inventor

Mishima-gun, Japan

Mikio Ogawa

USPTO Granted Patents = 8

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 111(Granted Patents)


Company Filing History:

goldMedal8 out of 574 
 
Ono Pharmaceutical Co., Ltd.
 patents

Years Active: 2004-2011

Loading Chart...
8 patents (USPTO):Explore Patents
1. 8026273 - 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient (2011-09-27),
2. 7786161 - Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient (2010-08-31),
3. 7683094 - 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient (2010-03-23),
4. 7491748 - Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient (2009-02-17),
5. 7402605 - 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient (2008-07-22),
6. 7378428 - Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient (2008-05-27),
7. 6956033 - 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient (2005-10-18),
8. 6835752 - Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient (2004-12-28),

Title: Mikio Ogawa: Innovator in Pharmaceutical Chemistry

Introduction

Mikio Ogawa, a prominent inventor based in Mishima-gun, Japan, has made significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 8 patents, Ogawa's work has the potential to impact the treatment of various immune and neurological diseases, showcasing his innovative approach to drug development.

Latest Patents

Among his latest inventions is an 8-azaprostaglandin derivative compound and agent comprising the compound as an active ingredient. This compound, represented by formula (I), binds strongly to the EP2 subtype among PGE receptors. Its potential applications are vast, addressing conditions such as immune diseases, allergic responses, neuronal cell death, dysmenorrhea, premature birth, and even baldness. Additionally, Ogawa has developed a carboxylic acid derivative of formula (I), which shows promise in treating pain, itching, allergic reactions, and various other diseases including Alzheimer's and certain cancers.

Career Highlights

Mikio Ogawa is affiliated with Ono Pharmaceutical Co., Ltd., a company renowned for its dedication to innovative therapeutic solutions. Throughout his career, Ogawa has focused on developing compounds that can effectively manage complex health conditions, underscoring his role as a leading inventor in the pharmaceutical industry.

Collaborations

Ogawa's contributions have been amplified through collaborations with esteemed colleagues such as Kousuke Tani and Kaoru Kobayashi. Together, they have worked on advancing research and bringing novel therapeutic agents to the forefront of medical science.

Conclusion

Mikio Ogawa's innovative spirit and commitment to pharmaceutical advancements are evident through his impressive patents and collaborations. As he continues to forge new paths in drug discovery, his work holds the promise of improving countless lives affected by chronic and complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…